Rtw Investments as of Sept. 30, 2018
Portfolio Holdings for Rtw Investments
Rtw Investments holds 46 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 22.1 | $369M | 15M | 24.62 | |
| Ptc Therapeutics I (PTCT) | 9.2 | $154M | 3.3M | 47.00 | |
| Arrowhead Pharmaceuticals (ARWR) | 8.7 | $146M | 7.6M | 19.17 | |
| Regenxbio Inc equity us cm (RGNX) | 6.6 | $110M | 1.5M | 75.50 | |
| Dicerna Pharmaceuticals | 5.0 | $83M | 5.5M | 15.26 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 4.3 | $72M | 3.7M | 19.35 | |
| Bristol Myers Squibb (BMY) | 3.5 | $59M | 947k | 62.08 | |
| Livanova Plc Ord (LIVN) | 3.3 | $55M | 443k | 123.97 | |
| Sarepta Therapeutics (SRPT) | 3.0 | $51M | 314k | 161.51 | |
| Achillion Pharmaceuticals | 3.0 | $50M | 14M | 3.68 | |
| Masimo Corporation (MASI) | 2.3 | $39M | 311k | 124.54 | |
| Arbutus Biopharma (ABUS) | 2.3 | $39M | 4.1M | 9.45 | |
| Corium Intl | 2.1 | $34M | 3.6M | 9.51 | |
| Alnylam Pharmaceuticals (ALNY) | 2.0 | $34M | 389k | 87.52 | |
| Viewray (VRAYQ) | 1.9 | $32M | 3.4M | 9.36 | |
| Vericel (VCEL) | 1.9 | $31M | 2.2M | 14.15 | |
| Illumina (ILMN) | 1.8 | $30M | 83k | 367.06 | |
| Qiagen Nv | 1.8 | $29M | 775k | 37.88 | |
| La Jolla Pharmaceuticl Com Par | 1.4 | $24M | 1.2M | 20.13 | |
| Agenus | 1.3 | $21M | 9.8M | 2.14 | |
| Establishment Labs Holdings Ord (ESTA) | 1.1 | $18M | 776k | 23.32 | |
| Myokardia | 1.1 | $18M | 274k | 65.20 | |
| Principia Biopharma | 1.0 | $17M | 644k | 26.95 | |
| ResMed (RMD) | 1.0 | $17M | 147k | 115.34 | |
| Bovie Medical Corporation | 0.9 | $16M | 2.2M | 7.10 | |
| Uniqure Nv (QURE) | 0.9 | $16M | 429k | 36.39 | |
| Solid Biosciences | 0.7 | $12M | 262k | 47.18 | |
| Pacific Biosciences of California (PACB) | 0.7 | $12M | 2.2M | 5.41 | |
| Caredx (CDNA) | 0.6 | $10M | 358k | 28.85 | |
| Homology Medicines | 0.6 | $9.9M | 435k | 22.86 | |
| Viking Therapeutics (VKTX) | 0.5 | $8.7M | 500k | 17.42 | |
| Viveve Med | 0.5 | $8.4M | 3.1M | 2.68 | |
| Electrocore | 0.4 | $7.2M | 514k | 14.00 | |
| Odonate Therapeutics Ord | 0.3 | $5.6M | 290k | 19.41 | |
| Nuvectra | 0.3 | $5.5M | 251k | 21.98 | |
| Novavax | 0.3 | $5.2M | 2.8M | 1.88 | |
| Neuronetics (STIM) | 0.3 | $5.0M | 158k | 32.06 | |
| Vivus Inc note 4.500% 5/0 | 0.2 | $3.2M | 4.0M | 0.80 | |
| Proteostasis Therapeutics In | 0.2 | $2.7M | 1.1M | 2.41 | |
| Argenx Se (ARGX) | 0.1 | $2.0M | 27k | 75.86 | |
| Ra Med Sys | 0.1 | $2.0M | 110k | 18.20 | |
| Tapimmune | 0.1 | $1.9M | 210k | 9.05 | |
| Novus Therapeutics | 0.1 | $1.5M | 316k | 4.67 | |
| Adverum Biotechnologies | 0.1 | $1.1M | 185k | 6.05 | |
| Bellicum Pharma | 0.1 | $970k | 158k | 6.16 | |
| Motus Gi Hldgs Incorporated | 0.0 | $303k | 60k | 5.09 |
